References
S. Volpato, J.M. Guralnik, L.P. Fried, A.T. Remaley, A.R. Cappola, L.J. Launer, Serum thyroxine level and cognitive decline in euthyroid older women. Neurology 58(7), 1055–1061 (2002). doi:10.1212/WNL.58.7.1055
M. Ganguli, L.A. Burmeister, E.C. Seaberg, S. Belle, S.T. DeKosky, Association between dementia and elevated TSH: a community-based study. Biol. Psychiatry 40(8), 714–725 (1996). doi:10.1016/0006-3223(95)00489-0
J.D. Davis, A. Podolanczuk, J.E. Donahue, E. Stopa, J.V. Hennessey, L.-G. Luo et al., Thyroid hormone levels in the prefrontal cortex of post-mortem brains of Alzheimer’s disease patients. Current Aging Sci. 1(3), 175–181 (2008). doi:10.1016/j.bbi.2008.05.010
S. Sampaolo, A. Campos-Barros, G. Mazziotti, S. Carlomagno, V. Sannino, G. Amato et al., Increased cerebrospinal fluid levels of 3,3′,5′-triiodothyronine in patients with Alzheimer’s disease. J. Clin. Endocrinol. Metab. 90(1), 198–202 (2005). doi:10.1210/jc.2004-1083
P. Johansson, E.G. Almqvist, J.-O. Johansson, N. Mattsson, O. Hansson, A. Wallin et al., Reduced cerebrospinal fluid level of thyroxine in patients with Alzheimer’s disease. Psychoneuroendocrinology 38(7), 1058–1066 (2013). doi:10.1016/j.psyneuen.2012.10.012
O.P. Soldin, S.J. Soldin, Thyroid hormone testing by tandem mass spectrometry. Clin. Biochem. 44(1), 89–94 (2011). doi:10.1016/j.clinbiochem.2010.07.020
G.M. McKhann, D.S. Knopman, H. Chertkow, B.T. Hyman, C.R. Jack, C.H. Kawas et al., The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimer’s Dement. 7(3), 263–269 (2011). doi:10.1016/j.jalz.2011.03.005
M.F. Folstein, S.E. Folstein, P.R. McHugh. Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12(3), 189–198 (1975). http://www.ncbi.nlm.nih.gov/pubmed/1202204
H. Reiber, K. Felgenhauer. Protein transfer at the blood cerebrospinal fluid barrier and the quantitation of the humoral immune response within the central nervous system. Clin. Chim. Acta 163(3), 319–328 (1987). http://www.ncbi.nlm.nih.gov/pubmed/3581475
G. Tibbling, H. Link, S. Ohman, Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values. Scand. J. Clin. Lab. Invest. 37(5), 385–390 (1977). doi:10.1080/00365517709091496
A. Saba, G. Chiellini, S. Frascarelli, M. Marchini, S. Ghelardoni, A. Raffaelli et al., Tissue distribution and cardiac metabolism of 3-iodothyronamine. Endocrinology 151(10), 5063–5073 (2010). doi:10.1210/en.2010-0491
B.K. Matuszewski, M.L. Constanzer, C.M. Chavez-Eng. Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. Anal. Chem. 75(13), 3019–3030 (2003). http://www.ncbi.nlm.nih.gov/pubmed/12964746
P.J. Taylor, Matrix effects: the Achilles heel of quantitative high-performance liquid chromatography-electrospray-tandem mass spectrometry. Clin. Biochem. 38(4), 328–334 (2005). doi:10.1016/j.clinbiochem.2004.11.007
M.B. Dratman, F.L. Crutchfield, M.B Schoenhoff. Transport of iodothyronines from bloodstream to brain: contributions by blood:brain and choroid plexus: cerebrospinal fluid barriers. Brain Res. 554(1–2), 229–236 (1991). http://www.ncbi.nlm.nih.gov/pubmed/1933305
A. Alkemade, E.C. Friesema, U.A. Unmehopa, B.O. Fabriek, G.G. Kuiper, J.L. Leonard et al., Neuroanatomical pathways for thyroid hormone feedback in the human hypothalamus. J. Clin. Endocrinol. Metab. 90(7), 4322–4334 (2005). doi:10.1210/jc.2004-2567
H.M. Tu, S.W. Kim, D. Salvatore, T. Bartha, G. Legradi, P.R. Larsen, R.M. Lechan, Regional distribution of type 2 thyroxine deiodinase messenger ribonucleic acid in rat hypothalamus and pituitary and its regulation by thyroid hormone. Endocrinology 138(8), 3359–3368 (1997). doi:10.1210/endo.138.8.5318
L. Luo, E.G. Stopa, Thyrotropin releasing hormone inhibits tau phosphorylation by dual signaling pathways in hippocampal neurons. J. Alzheimer’s Dis. 6(5), 527–536 (2004)
M.J. Latasa, B. Belandia, A. Pascual, Thyroid hormones regulate beta-amyloid gene splicing and protein secretion in neuroblastoma cells. Endocrinology 139(6), 2692–2698 (1998). doi:10.1210/endo.139.6.6033
N. Kimura, T. Kumamoto, H. Masuda, T. Hanaoka, Y. Hazama, T. Okazaki, R. Arakawa. Relationship between thyroid hormone levels and regional cerebral blood flow in Alzheimer disease. Alzheimer Dis. Assoc. Disord. 25(2), 138–143 (2011). doi:10.1097/WAD.0b013e3181f9aff2
M. Haji, N. Kimura, T. Hanaoka, Y. Aso, M. Takemaru, T. Hirano, E. Matsubara, Evaluation of regional cerebral blood flow in Alzheimer’s disease patients with subclinical hypothyroidism. Dement. Geriatr. Cogn. Disord. 39(5–6), 360–367 (2015). doi:10.1159/000375298
Funding
This work was supported by a local Grant of University of Pisa to RZ.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
There is no conflict of interest for any author.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Accorroni, A., Giorgi, F.S., Donzelli, R. et al. Thyroid hormone levels in the cerebrospinal fluid correlate with disease severity in euthyroid patients with Alzheimer’s disease. Endocrine 55, 981–984 (2017). https://doi.org/10.1007/s12020-016-0897-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-016-0897-6